Samsung Electronics Co.; Ltd.;SAMSUNG ELECTRONICS CO LTD
发明人:
申请号：
EP14162885.9
公开号：
EP2786765B1
申请日:
2014.03.31
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Provided is a composition for use in combination therapy for prevention or treatment of a cancer including a FGFR inhibitor and an anti-c-Met antibody or an antigen-binding fragment thereof as active ingredients. The composition for use in combination therapy can achieve an excellent synergistic effect and lower the effective dose of the anti-c-Met antibody, thereby enabling a more effective cancer treatment.
